Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03693612
Title GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

skin melanoma

transitional cell carcinoma

head and neck squamous cell carcinoma

prostate adenocarcinoma

clear cell renal cell carcinoma

lung non-small cell carcinoma

Therapies

GSK3359609 + Tremelimumab

Paclitaxel

Docetaxel

Cetuximab

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.